Mawatari, T <br/><br/>
Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials.  [electronic resource] 

 -  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA  04 2017 
 - 1279-1286 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis 
<br/><br/><label>ISSN: </label>1433-2965 
<br/><br/><label>Standard No.: </label>10.1007/s00198-016-3848-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--therapeutic use<br/>Clinical Trials, Phase III as Topic<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Lumbar Vertebrae--physiopathology<br/>Male<br/>Middle Aged<br/>Osteoporosis--blood<br/>Osteoporotic Fractures--etiology<br/>Randomized Controlled Trials as Topic<br/>Risedronic Acid--therapeutic use<br/>Spinal Fractures--etiology<br/>Vitamin D--analogs & derivatives<br/>Vitamin D Deficiency--blood